ArticleAntimicrobial agents and chemotherapy2019

Cost-effectiveness of ceftazidime-avibactam for treatment of carbapenem-resistant

Matthew S Simon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.